Patent details

301332 Product Name: garadacimab

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
301332
Type:
Certificate
SPC Type:
Medical
Basic Patent Number:
EP2734552
Status:
Application Pending
Application number:
301332
Procedural language:
Dutch
First Applicant Residence Country:
Germany (DE)

Marketing Authorization

Marketing Authorization Number:
EU/1/24/1885
Marketing Authorization Type:
EEA
Marketing Authorization Date:
12/02/2025
Marketing Authorization Country:
European Union (EU)

Dates

Filing date:
17/06/2025
First Marketing Authorization date:
12/02/2025
Grant date:
Activation date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Registration date:
17/06/2025
SPC/SPC Extension Expiration Date:
Lapsed By Expiration Date:
Withdrawal date:
Revocation Date:
Invalidity Date:
Withdrawal Market Authorization Date:
Refusal Date:

Applicant/holder

From:
17/06/2025
 
 

 

Name:
CSL Behring GmbH
Address:
Emil-von-Behring-Strasse 76, 35041, MARBURG, Germany (DE)

From:
17/06/2025
 
 

 

Name:
CSL Limited
Address:
655 Elizabeth Street, 3000, Melbourne VIC , Australia (AU)

Agent

Name:
dr. R.C. van Duijvenbode c.s.
From:
17/06/2025
Address:
NLO Postbus 29720, 2502 LS, Den Haag, Netherlands (NL)
To:

Publication

Bulletin

Bulletin Heading:
SPC
Journal edition number:
25/25
Publication date:
18/06/2025
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
Filing date Document type Document Description Number of pages File Type
17/06/2025 Application Form First filed application form 2 PDF /2/0/4/4/2/0801124402/docs/301332_0_applicationform20250617035101268.pdf
17/06/2025 SPC Documents Summary of the characteristics of the product 12 PDF /2/0/4/4/2/0801124402/docs/301332_1_supplprotectioncertificate20250617035201108.pdf
17/06/2025 SPC Documents Marketing Authorization SPC 3 PDF /2/0/4/4/2/0801124402/docs/301332_2_supplprotectioncertificate20250617035335239.pdf
17/06/2025 SPC Documents Annex SPC 1 PDF /2/0/4/4/2/0801124402/docs/301332_3_supplprotectioncertificate20250617035412593.pdf
17/06/2025 SPC Documents Annex SPC 2 PDF /2/0/4/4/2/0801124402/docs/301332_4_supplprotectioncertificate20250617035452347.pdf
17/06/2025 Outgoing Correspondence Confirmation receipt request 2 PDF /2/0/4/4/2/0801124402/docs/301332_5_661045l174.pdf